No human clinical trials have been published as of 2026
LaPelusa, A., & Kaushik, R
[DOI] [PubMed] [Google Scholar] 131.Cesar L.B., Gojkovic S., Krezic I., Malekinusic D., Zizek H., Vuletic L.B., Petrovic A., Pavlov K.H., Drmic D., Kokot A., et al
The glutathione peptide of one inhibitor, termed productive binding, occupies the G-subsite with multiple interactions similar to those observed for other glutathione S-transferases, while the glutathione backbone of the second inhibitor, termed unproductive binding, exhibits only weak interactions mediated by two polar contacts
The Research-Based Decision Guide Durham Peptides Apr 19 7 min read Updated: 1 day ago GLOW Blend vs GHK-Cu peptide research comparison Durham Peptides Canada One of the most frequent questions Durham Peptides receives from researchers in Canada is whether to choose the GLOW Blend or GHK-Cu on its own
[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Smoday I.M., Petrovic I., Kalogjera L., Vranes H., Zizek H., Krezic I., Gojkovic S., Skorak I., Hriberski K., Brizic I., et al